EX-99.1
Published on February 26, 2026
Exhibit 99.1
Perimeter Solutions Reports Fourth Quarter 2025 Financial Results
February 26, 2026
Full year Net Loss of $206.4M and Adjusted Net Income of $206.7M
Continued value driver execution drove full year Adjusted EBITDA of $331.7M
Full year Loss Per Diluted Share of $1.37 and Adjusted Earnings Per Diluted Share of $1.34
Specialty Products Segment acquired add-on product lines in Q4 2025, and MMT in Q1 2026
Clayton, Missouri, February 26, 2026 – Perimeter Solutions, Inc. (NYSE: PRM) (“Perimeter,” “Perimeter Solutions,” or the “Company”), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, today reported financial results for its fourth quarter, and full year, ended December 31, 2025.
Full Year 2025 Results
•Net sales increased 16% to $652.9 million, as compared to $561.0 million in the prior year.
•Fire Safety net sales increased 12% to $489.0 million, as compared to $436.3 million in the prior year.
•Specialty Products net sales increased 31% to $163.9 million, as compared to $124.7 million in the prior year.
•Net loss was $206.4 million, or $1.37 loss per diluted share, as compared to a net loss of $5.9 million, or $0.04 loss per diluted share in the prior year.
•Non-GAAP adjusted earnings per diluted share was $1.34, as compared to non-GAAP adjusted earnings per share of $1.11 in the prior year.
•Adjusted EBITDA increased 18% to $331.7 million, as compared to $280.3 million in the prior year.
•Fire Safety Segment Adjusted EBITDA increased 21% to $290.5 million, as compared to $240.1 million in the prior year.
•Specialty Products Segment Adjusted EBITDA increased 3% to $41.2 million, as compared to $40.2 million in the prior year.
•Reconciliation tables for non-GAAP measures are available in the attached schedules.
Fourth Quarter 2025 Results
•Net sales increased 19% to $102.8 million in the fourth quarter, as compared to $86.2 million in the prior year quarter.
•Fire Safety net sales decreased 4% to $58.1 million, as compared to $60.7 million in the prior year quarter.
•Specialty Products net sales increased 75% to $44.7 million, as compared to $25.5 million in the prior year quarter.
•Net loss during the fourth quarter was $140.2 million, or $0.94 loss per diluted share, as compared to net income of $144.2 million, or $0.90 earnings per diluted share in the prior year quarter.
•Fourth quarter non-GAAP adjusted earnings per diluted share was $0.13 for both the quarter ended 2025 and 2024.
•Adjusted EBITDA increased 9% to $36.0 million in the fourth quarter, as compared to $32.9 million in the prior year quarter.
•Fire Safety Segment Adjusted EBITDA decreased 6% to $25.6 million, as compared to $27.2 million in the prior year quarter.
•Specialty Products Segment Adjusted EBITDA increased 85% to $10.4 million, as compared to $5.6 million in the prior year quarter.
•Reconciliation tables for non-GAAP measures are available in the attached schedules.
Capital Allocation
•The Company invested $7.0 million in capital expenditures for the three months ended December 31, 2025 and $29.6 million for the year ended December 31, 2025.
•On November 14, 2025, the Company acquired substantially all of the assets and technical data rights of certain electro-optical product lines from a third party, for a total cash purchase price of $40.0 million. The product lines will be included within the Specialty Products Segment.
•On January 22, 2026, the Company acquired the outstanding capital stock of Medical Manufacturing Technologies, LLC (“MMT”) for a total cash purchase price of $685.0 million which was funded with cash on hand and proceeds from a senior secured notes offering. The Company expects that MMT will be included within its Specialty Products segment.
Conference Call and Webcast
As previously announced, Perimeter Solutions management will hold a conference call at 8:30 a.m. ET on Thursday, February 26, 2026 to discuss financial results for the fourth quarter and full year 2025. The conference call can be accessed by dialing (877) 407-9764 (toll-free) or (201) 689-8551 (toll).
The conference call will also be webcast simultaneously on Perimeter’s website (https://ir.perimeter-solutions.com), accessed under the Investor Relations page. The webcast link will be made available on the Company's website prior to the start of the call; go to the investor relations page of our website to the News & Events menu and click on “Events & Presentations.”
A slide presentation will also be available for reference during the conference call; go to the investor relations page of our website to the News & Events menu and click on “Events & Presentations.”
Following the live webcast, a replay will be available on the Company’s website. A telephonic replay will also be available approximately three hours after the call and can be accessed by dialing (877) 660-6853 (toll-free) or (201) 612-7415 (toll) and using Access ID “13758339”. The telephonic replay will be available until March 26, 2026 (11:59 p.m. ET).
About Perimeter Solutions
Perimeter Solutions (NYSE: PRM) is a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications. Perimeter’s focus on superior customer service, paired with our Value Driver-focused operating strategy, decentralized operating model, and focus on driving value via capital allocation and capital structure management, fulfills our dual mandate: to serve customers and create value for stockholders. Perimeter is comprised of two segments, Fire Safety, including fire retardants and fire suppressants, and Specialty Products, which currently spans lubricant additives, electronic and electro-mechanical components, and highly engineered machinery for the medical device industry. Perimeter expects to continue expanding its portfolio through organic growth and value creating acquisitions.
Forward-looking Information
This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will,” and similar references to future periods.
Any such forward-looking statements are not guarantees of performance or results, and involve risks, uncertainties (some of which are beyond the Company’s control) and assumptions. Although Perimeter believes any forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect the Company’s actual financial results and cause them to differ materially from those anticipated in any forward-looking statements, including the risk factors described from time to time by us in our filings with the Securities and Exchange Commission (“SEC”), including, but not limited to, the Company’s Annual Report on Form 10-K for the year ended December 31, 2025. Stockholders, potential investors and other readers should consider these factors carefully in evaluating the forward-looking statements.
Any forward-looking statement made by Perimeter in this press release speaks only as of the date on which it is made. Perimeter undertakes no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
SOURCE: Perimeter Solutions, Inc.
CONTACT: ir@perimeter-solutions.com
PERIMETER SOLUTIONS, INC. AND SUBSIDIARIES
Consolidated Statements of Operations and Comprehensive (Loss) Income
(in thousands, except share and per share data)
(Unaudited)
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net sales | $ | 102,750 | $ | 86,231 | $ | 652,862 | $ | 560,968 | |||||||||||||||
| Cost of goods sold | 56,358 | 44,336 | 277,712 | 243,882 | |||||||||||||||||||
| Gross profit | 46,392 | 41,895 | 375,150 | 317,086 | |||||||||||||||||||
| Operating expenses (income): | |||||||||||||||||||||||
| Selling, general and administrative expense | 21,832 | 21,013 | 77,575 | 66,901 | |||||||||||||||||||
| Amortization expense | 15,794 | 13,741 | 59,696 | 55,032 | |||||||||||||||||||
| Founders advisory fees - related party | 171,209 | (54,789) | 435,163 | 198,308 | |||||||||||||||||||
| Other operating expense | 2,721 | 612 | 3,646 | 612 | |||||||||||||||||||
| Total operating expenses (income) | 211,556 | (19,423) | 576,080 | 320,853 | |||||||||||||||||||
| Operating (loss) income | (165,164) | 61,318 | (200,930) | (3,767) | |||||||||||||||||||
| Other expense (income): | |||||||||||||||||||||||
| Interest expense, net | 9,691 | 9,169 | 39,135 | 40,461 | |||||||||||||||||||
| Foreign currency loss (gain) | 211 | 2,280 | (3,038) | 2,443 | |||||||||||||||||||
| Other (income) expense, net | (638) | (60) | (780) | 192 | |||||||||||||||||||
| Total other expense, net | 9,264 | 11,389 | 35,317 | 43,096 | |||||||||||||||||||
| (Loss) income before income taxes | (174,428) | 49,929 | (236,247) | (46,863) | |||||||||||||||||||
| Income tax benefit | 34,197 | 94,241 | 29,881 | 40,958 | |||||||||||||||||||
| Net (loss) income | (140,231) | 144,170 | (206,366) | (5,905) | |||||||||||||||||||
| Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
| Foreign currency translation adjustments | 3,184 | (23,627) | 32,862 | (19,522) | |||||||||||||||||||
| Total comprehensive (loss) income | $ | (137,047) | $ | 120,543 | $ | (173,504) | $ | (25,427) | |||||||||||||||
| (Loss) earnings per share: | |||||||||||||||||||||||
| Basic | $ | (0.94) | $ | 0.98 | $ | (1.37) | $ | (0.04) | |||||||||||||||
| Diluted | $ | (0.94) | $ | 0.90 | $ | (1.37) | $ | (0.04) | |||||||||||||||
| Weighted average number of shares outstanding: | |||||||||||||||||||||||
| Basic | 148,808,784 | 147,058,719 | 150,370,533 | 145,713,439 | |||||||||||||||||||
| Diluted | 148,808,784 | 160,931,755 | 150,370,533 | 145,713,439 | |||||||||||||||||||
PERIMETER SOLUTIONS, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
(in thousands, except share data)
(Unaudited)
| December 31, 2025 | December 31, 2024 | ||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 325,927 | $ | 198,456 | |||||||
| Accounts receivable, net | 64,363 | 56,048 | |||||||||
| Inventories | 139,634 | 116,347 | |||||||||
| Prepaid expenses and other current assets | 34,049 | 23,173 | |||||||||
| Total current assets | 563,973 | 394,024 | |||||||||
| Property, plant and equipment, net | 85,138 | 64,777 | |||||||||
| Operating lease right-of-use assets | 30,152 | 17,298 | |||||||||
| Finance lease right-of-use assets | 5,713 | 6,173 | |||||||||
| Goodwill | 1,065,211 | 1,034,543 | |||||||||
| Customer lists, net | 628,189 | 637,745 | |||||||||
| Technology and patents, net | 184,804 | 173,307 | |||||||||
| Tradenames, net | 86,330 | 87,365 | |||||||||
| Other assets, net | 3,497 | 1,162 | |||||||||
| Total assets | $ | 2,653,007 | $ | 2,416,394 | |||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 30,301 | $ | 23,519 | |||||||
| Accrued expenses and other current liabilities | 47,212 | 30,450 | |||||||||
| Founders advisory fees payable - related party | 95,726 | 6,677 | |||||||||
| Deferred revenue | 1,879 | 1,842 | |||||||||
| Total current liabilities | 175,118 | 62,488 | |||||||||
| Long-term debt, net | 669,122 | 667,774 | |||||||||
| Operating lease liabilities, net of current portion | 27,860 | 15,540 | |||||||||
| Finance lease liabilities, net of current portion | 5,694 | 6,013 | |||||||||
| Deferred income taxes | 80,410 | 152,203 | |||||||||
| Founders advisory fees payable - related party | 440,697 | 240,083 | |||||||||
| Preferred stock | 115,904 | 109,966 | |||||||||
| Preferred stock - related party | 1,293 | 2,831 | |||||||||
| Other non-current liabilities | 3,590 | 2,226 | |||||||||
| Total liabilities | 1,519,688 | 1,259,124 | |||||||||
| Commitments and contingencies | |||||||||||
| Stockholders’ equity: | |||||||||||
Common stock, $0.0001 par value per share, 4,000,000,000 shares authorized; 174,818,216 and 169,426,114 shares issued; 149,440,060 and 147,822,633 shares outstanding at December 31, 2025 and 2024, respectively | 17 | 17 | |||||||||
Treasury stock, at cost; 25,378,156 and 21,603,481 shares at December 31, 2025 and 2024, respectively | (168,197) | (127,827) | |||||||||
| Additional paid-in capital | 2,100,958 | 1,911,035 | |||||||||
| Accumulated other comprehensive loss | (6,370) | (39,232) | |||||||||
| Accumulated deficit | (793,089) | (586,723) | |||||||||
| Total stockholders’ equity | 1,133,319 | 1,157,270 | |||||||||
| Total liabilities and stockholders’ equity | $ | 2,653,007 | $ | 2,416,394 | |||||||
PERIMETER SOLUTIONS, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(in thousands)
(Unaudited)
| Year Ended December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net loss | $ | (206,366) | $ | (5,905) | |||||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||||||
| Founders advisory fees - related party (change in fair value) | 435,163 | 198,308 | |||||||||
| Depreciation and amortization expense | 74,032 | 65,718 | |||||||||
| Interest and payment-in-kind on preferred stock | 7,332 | 7,057 | |||||||||
| Stock-based compensation | 16,647 | 12,849 | |||||||||
| Non-cash lease expense | 6,861 | 5,070 | |||||||||
| Deferred income taxes | (74,144) | (99,557) | |||||||||
| Amortization of deferred financing costs | 1,907 | 1,730 | |||||||||
| Foreign currency (gain) loss | (3,038) | 2,443 | |||||||||
| Loss on disposal of assets | 149 | 66 | |||||||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||||||||
| Accounts receivable | (6,954) | (13,293) | |||||||||
| Inventories | (5,980) | 29,872 | |||||||||
| Prepaid expenses and other current assets | 971 | (843) | |||||||||
| Accounts payable | 6,228 | (754) | |||||||||
| Deferred revenue | 37 | 1,842 | |||||||||
| Income taxes payable, net | (5,685) | (13,299) | |||||||||
| Accrued expenses and other current liabilities | 4,159 | 4,306 | |||||||||
| Founders advisory fees - related party (cash settled) | (6,677) | (2,702) | |||||||||
| Operating lease liabilities | (4,867) | (3,278) | |||||||||
| Finance lease liabilities | (489) | (501) | |||||||||
| Other, net | (1,137) | (741) | |||||||||
| Net cash provided by operating activities | 238,149 | 188,388 | |||||||||
| Cash flows from investing activities: | |||||||||||
| Purchase of property and equipment | (29,591) | (15,531) | |||||||||
| Purchase of intangible assets | (15,226) | — | |||||||||
| Proceeds from short-term investments | — | 5,383 | |||||||||
| Purchase of businesses, net of cash acquired | (62,000) | (32,792) | |||||||||
| Net cash used in investing activities | (106,817) | (42,940) | |||||||||
| Cash flows from financing activities: | |||||||||||
| Common stock repurchased | (40,370) | — | |||||||||
| Ordinary shares repurchased | — | (14,420) | |||||||||
| Proceeds from exercises of warrants | — | 23,509 | |||||||||
| Proceeds from exercises of options | 34,453 | — | |||||||||
| Principal payments on finance lease obligations | (875) | (740) | |||||||||
| Payment for credit facility financing fees | (2,179) | — | |||||||||
| Net cash (used in) provided by financing activities | (8,971) | 8,349 | |||||||||
| Effect of foreign currency on cash and cash equivalents | 5,110 | (2,617) | |||||||||
| Net change in cash and cash equivalents | 127,471 | 151,180 | |||||||||
| Cash and cash equivalents, beginning of period | 198,456 | 47,276 | |||||||||
| Cash and cash equivalents, end of period | $ | 325,927 | $ | 198,456 | |||||||
| Supplemental disclosures of cash flow information: | |||||||||||
| Cash paid for interest | $ | 36,745 | $ | 37,317 | |||||||
| Cash paid for income taxes | $ | 48,851 | $ | 74,559 | |||||||
| Non-cash activities: | |||||||||||
| Liability portion of founders advisory fees - related party reclassified to additional paid in capital | $ | 138,823 | $ | 8,464 | |||||||
Non-GAAP Financial Metrics
The Company provides non-GAAP financial measures for Segment Adjusted EBITDA, Adjusted Net Income, and Adjusted Earnings Per Share data as supplemental information regarding the Company’s business performance. The Company believes that these non-GAAP financial measures are useful to investors because they provide investors with a better understanding of the Company’s past financial performance and future results. The Company’s management uses these non-GAAP financial measures when it internally evaluates the performance of its business and makes operating decisions, including internal operating budgeting, performance measurement, and discretionary compensation.
Segment Adjusted EBITDA
Segment Adjusted EBITDA is defined as (loss) income before income taxes plus net interest and other financing expenses, and depreciation and amortization, adjusted on a consistent basis for certain non-recurring, unusual or non-operational items. These items include (i) restructuring, (ii) acquisition related costs, (iii) founder advisory fee expenses, (iv) stock-based compensation expense and (v) foreign currency loss (gain). To supplement the Company’s consolidated financial statements presented in accordance with U.S. GAAP, Perimeter is providing a summary to show the computations of Segment Adjusted EBITDA, which is a non-GAAP measure used by the Company's management and by external users of Perimeter’s financial statements, such as debt and equity investors, commercial banks and others, to assess the Company’s operating performance as compared to that of other companies, without regard to financing methods, capital structure or historical cost basis. Segment Adjusted EBITDA should not be considered an alternative to net (loss) income, operating (loss) income, cash flows provided by operating activities or any other measure of financial performance or liquidity presented in accordance with U.S. GAAP (in thousands).
| (Unaudited) | Three Months Ended December 31, 2025 | Three Months Ended December 31, 2024 | |||||||||||||||||||||||||||||||||
| Fire Safety | Specialty Products | Total | Fire Safety | Specialty Products | Total | ||||||||||||||||||||||||||||||
| (Loss) income before income taxes | $ | (152,325) | $ | (22,103) | $ | (174,428) | $ | 45,304 | $ | 4,625 | $ | 49,929 | |||||||||||||||||||||||
| Depreciation and amortization | 14,579 | 5,843 | 20,422 | 12,858 | 3,645 | 16,503 | |||||||||||||||||||||||||||||
| Interest and financing expense (benefit) | 5,969 | 3,722 | 9,691 | 9,694 | (525) | 9,169 | |||||||||||||||||||||||||||||
| Founders advisory fees - related party | 154,106 | 17,103 | 171,209 | (46,936) | (7,853) | (54,789) | |||||||||||||||||||||||||||||
Non-recurring expenses (1) | 137 | 775 | 912 | 3,743 | 626 | 4,369 | |||||||||||||||||||||||||||||
| Acquisition costs | — | 2,716 | 2,716 | — | 612 | 612 | |||||||||||||||||||||||||||||
| Stock-based compensation expense | 3,390 | 1,829 | 5,219 | 2,735 | 2,066 | 4,801 | |||||||||||||||||||||||||||||
| Foreign currency (gain) loss | (323) | 534 | 211 | (154) | 2,434 | 2,280 | |||||||||||||||||||||||||||||
| Segment Adjusted EBITDA | $ | 25,533 | $ | 10,419 | $ | 35,952 | $ | 27,244 | $ | 5,630 | $ | 32,874 | |||||||||||||||||||||||
| (1) | For the three months ended December 31, 2025, $0.7 million was related to litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company and $0.2 million was related to the redomiciliation of the Company from Luxembourg to Delaware (the “Redomiciliation Transaction”). For the three months ended December 31, 2024, $4.4 million was related to the Redomiciliation Transaction and other non-recurring Luxembourg related costs. | |||||||||||||
| (Unaudited) | Year Ended December 31, 2025 | Year Ended December 31, 2024 | |||||||||||||||||||||||||||||||||
| Fire Safety | Specialty Products | Total | Fire Safety | Specialty Products | Total | ||||||||||||||||||||||||||||||
| Loss before income taxes | $ | (182,537) | $ | (53,710) | $ | (236,247) | $ | (35,277) | $ | (11,586) | $ | (46,863) | |||||||||||||||||||||||
| Depreciation and amortization | 55,397 | 18,635 | 74,032 | 51,365 | 14,353 | 65,718 | |||||||||||||||||||||||||||||
| Interest and financing expense | 24,059 | 15,076 | 39,135 | 39,547 | 914 | 40,461 | |||||||||||||||||||||||||||||
| Founders advisory fees - related party | 381,106 | 54,057 | 435,163 | 169,886 | 28,422 | 198,308 | |||||||||||||||||||||||||||||
Non-recurring expenses (1) | 955 | 1,465 | 2,420 | 5,559 | 1,207 | 6,766 | |||||||||||||||||||||||||||||
| Acquisition costs | 98 | 3,480 | 3,578 | — | 612 | 612 | |||||||||||||||||||||||||||||
| Stock-based compensation expense | 12,207 | 4,440 | 16,647 | 8,545 | 4,304 | 12,849 | |||||||||||||||||||||||||||||
| Foreign currency (gain) loss | (798) | (2,240) | (3,038) | 496 | 1,947 | 2,443 | |||||||||||||||||||||||||||||
| Segment Adjusted EBITDA | $ | 290,487 | $ | 41,203 | $ | 331,690 | $ | 240,121 | $ | 40,173 | $ | 280,294 | |||||||||||||||||||||||
| (1) | For the year ended December 31, 2025, $1.1 million was related to restructuring and other non-recurring costs, $0.7 million was related to litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company, and $0.6 million was related to the Redomiciliation Transaction. For the year ended December 31, 2024, $6.6 million was related to the Redomiciliation Transaction and other non-recurring Luxembourg related costs and $0.2 million was related to other non-recurring costs. | |||||||||||||
Adjusted Net Income and Adjusted Earnings Per Share
The computation of Adjusted Earnings Per Share (“Adjusted EPS”) is defined as Adjusted Net Income divided by adjusted diluted shares. Adjusted Net Income is defined as net (loss) income plus amortization, certain non-recurring, unusual or non-operational items, and the tax impact of these non-GAAP adjustments. These adjustments include (i) restructuring, (ii) acquisition related costs, (iii) founder advisory fee expenses, (iv) stock-based compensation expense and (v) foreign currency loss (gain). Adjusted diluted shares is the weighted average diluted shares outstanding, adjusted by adding dilution for options and warrants excluded under U.S. GAAP due to a net loss, less dilution related to founders advisory fees. To supplement the Company’s consolidated financial statements presented in accordance with U.S. GAAP, Perimeter is providing a summary to show the computations of Adjusted Net Income and Adjusted EPS, which are non-GAAP measures used by the Company's management and by external users of Perimeter’s financial statements, such as debt and equity investors, commercial banks and others, to assess the Company's operating performance as compared to that of other companies, without regard to financing methods, capital structure or historical cost basis. Adjusted EPS and Adjusted Net Income should not be considered alternatives to GAAP (loss) earnings per share (“GAAP EPS”), net (loss) income, operating (loss) income, cash flows provided by operating activities or any other measure of financial performance or liquidity presented in accordance with U.S. GAAP (in thousands, except share and per share data).
| (Unaudited) | Three Months Ended December 31, | ||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| GAAP net (loss) income | $ | (140,231) | $ | 144,170 | |||||||||||||
| Adjustments: | |||||||||||||||||
| Amortization | 15,794 | 13,741 | |||||||||||||||
| Founders advisory fees - related party | 171,209 | (54,789) | |||||||||||||||
Non-recurring expenses (1) | 912 | 4,369 | |||||||||||||||
| Acquisition costs | 2,716 | 612 | |||||||||||||||
| Stock-based compensation expense | 5,219 | 4,801 | |||||||||||||||
| Foreign currency loss | 211 | 2,280 | |||||||||||||||
Tax impact of non-GAAP adjustments (2) | (35,937) | (96,136) | |||||||||||||||
| Adjusted net income | $ | 19,893 | $ | 19,048 | |||||||||||||
| Shares used in computing GAAP (Loss) Earnings Per Share (diluted) | 148,808,784 | 160,931,755 | |||||||||||||||
Options (3) | 7,136,522 | — | |||||||||||||||
Shares underlying Founders fixed advisory fees (4) | — | (9,428,244) | |||||||||||||||
Shares underlying Founders variable advisory fees (5) | — | — | |||||||||||||||
| Shares used in computing Adjusted Earnings Per Share (diluted) | 155,945,306 | 151,503,511 | |||||||||||||||
| GAAP (Loss) Earnings Per Share (diluted) | $ | (0.94) | $ | 0.90 | |||||||||||||
| Adjusted Earnings Per Share (diluted) | $ | 0.13 | $ | 0.13 | |||||||||||||
| ____________________ | |||||||||||||||||
| (1) | For the three months ended December 31, 2025, $0.7 million was related to litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company and $0.2 million was related to the Redomiciliation Transaction. For the three months ended December 31, 2024, $4.4 million was related to the Redomiciliation Transaction and other non-recurring Luxembourg related costs. | ||||||||||||||||
| (2) | The tax impact of non-GAAP adjustments reflects the total income tax expense commensurate with the non-GAAP measure of profitability. | ||||||||||||||||
| (3) | The Company adds back the dilutive impact of options if amounts were excluded for purposes of GAAP EPS due to a GAAP net loss during the period. | ||||||||||||||||
| (4) | As of December 31, 2025, a maximum of 2.4 million shares were issuable within 12 months under the Founders fixed advisory fee. To satisfy the 2025 Founders fixed advisory fee, the Company paid $13.4 million in cash on February 19, 2026 and expects to issue 1.9 million shares of Common Stock in the first quarter of 2026. | ||||||||||||||||
| (5) | Based on period end market prices as of December 31, 2025, a maximum of 14.5 million shares were issuable within 12 months under the Founders variable advisory fee. To satisfy the 2025 Founders variable advisory fee, the Company paid $82.3 million in cash on February 19, 2026 and expects to issue 11.5 million shares of Common Stock in the first quarter of 2026. | ||||||||||||||||
| (Unaudited) | Year Ended December 31, | ||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| GAAP net loss | $ | (206,366) | $ | (5,905) | |||||||||||||
| Adjustments: | |||||||||||||||||
| Amortization | 59,696 | 55,032 | |||||||||||||||
| Founders advisory fees - related party | 435,163 | 198,308 | |||||||||||||||
Non-recurring expenses (1) | 2,420 | 6,766 | |||||||||||||||
| Acquisition costs | 3,578 | 612 | |||||||||||||||
| Stock-based compensation expense | 16,647 | 12,849 | |||||||||||||||
| Foreign currency (gain) loss | (3,038) | 2,443 | |||||||||||||||
Tax impact of non-GAAP adjustments (2) | (101,427) | (106,715) | |||||||||||||||
| Adjusted net income | $ | 206,673 | $ | 163,390 | |||||||||||||
| Shares used in computing GAAP (Loss) Earnings Per Share (diluted) | 150,370,533 | 145,713,439 | |||||||||||||||
Options (3) | 4,092,617 | 1,446,487 | |||||||||||||||
Warrants (3) | — | 49,876 | |||||||||||||||
Shares underlying Founders fixed advisory fees (4) | — | — | |||||||||||||||
Shares underlying Founders variable advisory fees (5) | — | — | |||||||||||||||
| Shares used in computing Adjusted Earnings Per Share (diluted) | 154,463,150 | 147,209,802 | |||||||||||||||
| GAAP (Loss) Earnings Per Share (diluted) | $ | (1.37) | $ | (0.04) | |||||||||||||
| Adjusted Earnings Per Share (diluted) | $ | 1.34 | $ | 1.11 | |||||||||||||
| ____________________ | |||||||||||||||||
| (1) | For the year ended December 31, 2025, $1.1 million was related to restructuring and other non-recurring costs, $0.7 million was related to litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company, and $0.6 million was related to the Redomiciliation Transaction. For the year ended December 31, 2024, $6.6 million was related to the Redomiciliation Transaction and other non-recurring Luxembourg related costs and $0.2 million was related to other non-recurring costs. | ||||||||||||||||
| (2) | The tax impact of non-GAAP adjustments reflects the total income tax expense commensurate with the non-GAAP measure of profitability. | ||||||||||||||||
| (3) | The Company adds back the dilutive impact of options and warrants if amounts were excluded for purposes of GAAP EPS due to GAAP net loss during the period. | ||||||||||||||||
| (4) | As of December 31, 2025, a maximum of 2.4 million shares were issuable within 12 months under the Founders fixed advisory fee. To satisfy the 2025 Founders fixed advisory fee, the Company paid $13.4 million in cash on February 19, 2026 and expects to issue 1.9 million shares of Common Stock in the first quarter of 2026. | ||||||||||||||||
| (5) | Based on period end market prices as of December 31, 2025, a maximum of 14.5 million shares were issuable within 12 months under the Founders variable advisory fee. To satisfy the 2025 Founders variable advisory fee, the Company paid $82.3 million in cash on February 19, 2026 and expects to issue 11.5 million shares of Common Stock in the first quarter of 2026. | ||||||||||||||||